Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Stem Cell Reports ; 17(1): 43-52, 2022 01 11.
Artigo em Inglês | MEDLINE | ID: mdl-34919812

RESUMO

Mammalian haploid cells have applications for genetic screening and substituting gametic genomes. Here, we characterize a culture system for obtaining haploid primordial germ cell-like cells (PGCLCs) from haploid mouse embryonic stem cells (ESCs). We find that haploid cells show predisposition for PGCLCs, whereas a large fraction of somatic cells becomes diploid. Characterization of the differentiating haploid ESCs (haESCs) reveals that Xist is activated from and colocalizes with the single X chromosome. This observation suggests that X chromosome inactivation (XCI) is initiated in haploid cells consistent with a model where autosomal blocking factors set a threshold for X-linked activators. We further find that Xist expression is lost at later timepoints in differentiation, which likely reflects the loss of X-linked activators. In vitro differentiation of haploid PGCLCs can be a useful approach for future studies of potential X-linked activators of Xist.


Assuntos
Células-Tronco Embrionárias/metabolismo , Células Germinativas/metabolismo , Haploidia , RNA Longo não Codificante/genética , Cromossomo X , Animais , Biomarcadores , Diferenciação Celular/genética , Células-Tronco Embrionárias/citologia , Dosagem de Genes , Regulação da Expressão Gênica no Desenvolvimento , Células Germinativas/citologia , Camundongos , Inativação do Cromossomo X
2.
Nat Chem Biol ; 15(12): 1191-1198, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31636429

RESUMO

Splicing modifiers promoting SMN2 exon 7 inclusion have the potential to treat spinal muscular atrophy, the leading genetic cause of infantile death. These small molecules are SMN2 exon 7 selective and act during the early stages of spliceosome assembly. Here, we show at atomic resolution how the drug selectively promotes the recognition of the weak 5' splice site of SMN2 exon 7 by U1 snRNP. The solution structure of the RNA duplex formed following 5' splice site recognition in the presence of the splicing modifier revealed that the drug specifically stabilizes a bulged adenine at this exon-intron junction and converts the weak 5' splice site of SMN2 exon 7 into a stronger one. The small molecule acts as a specific splicing enhancer cooperatively with the splicing regulatory network. Our investigations uncovered a novel concept for gene-specific alternative splicing correction that we coined 5' splice site bulge repair.


Assuntos
Splicing de RNA , RNA/química , Conformação Molecular , Atrofia Muscular Espinal/metabolismo , Ribonucleoproteína Nuclear Pequena U1/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA